Clinical Trials in Xinjiang, China
Locations / Xinjiang, China
Delta Trials hosts 46 clinical trials conducted in Xinjiang, China, making it a notable site of clinical research activity. These trials covering 80 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Xinjiang.
46
Total Trials
80
Conditions
1
Terminated since 2020
Browse by condition (80 total)
- Acute myocardial infarction 2 trialsAll Acute myocardial infarction trials
- Chronic heart failure 2 trialsAll Chronic heart failure trials
- Depression 1 trialAll Depression trials
- Sudden cardiac arrest 1 trialAll Sudden cardiac arrest trials
- Advanced breast cancer 1 trialAll Advanced breast cancer trials
- Liver cirrhosis 1 trialAll Liver cirrhosis trials
- Healthy adult 1 trialAll Healthy adult trials
- Hip fractures 1 trialAll Hip fractures trials
- Fallopian tube cancer 1 trialAll Fallopian tube cancer trials
- Hepatic flexure colon cancer 1 trialAll Hepatic flexure colon cancer trials
- Hcc 1 trialAll Hcc trials
- Alcohol abuse 1 trialAll Alcohol abuse trials
- Benign prostatic hyperplasia 1 trialAll Benign prostatic hyperplasia trials
- All Avascular necrosis of femoral head trials
- Hip dislocation 1 trialAll Hip dislocation trials
- All Relapsed or refractory mantle cell lymphoma (mcl) trials
- Herpes zoster 1 trialAll Herpes zoster trials
- Hemorrhage, postpartum 1 trialAll Hemorrhage, postpartum trials
- All Atypical hemolytic uremic syndrome (ahus) trials
- Hbv 1 trialAll Hbv trials